NCT07216079 Rilzabrutinib for the Adult Participants With Chronic ITP Who Have Completed Phase 3 Study in Japan Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT07190196 A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease Status RECRUITING Phase PHASE3
NCT07086976 A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia Status RECRUITING Phase PHASE3
NCT07007962 Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment Status RECRUITING Phase PHASE3
NCT06975865 The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease Status RECRUITING Phase PHASE3
NCT06500702 A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease Status RECRUITING Phase PHASE2
NCT06444204 A Study to Evaluate the Effect of Mild and Moderate Hepatic Impairment on the Single-Dose Pharmacokinetics of Rilzabrutinib (PRN1008) Status COMPLETED Phase PHASE1
NCT06444191 Pharmacokinetics (PK) of Rilzabrutinib (PRN1008) in Healthy Japanese and Caucasian Subjects Status COMPLETED Phase PHASE1
NCT05107115 Rilzabrutinib for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine Status COMPLETED Phase PHASE2
NCT05104892 Proof of Concept Study of Rilzabrutinib in Adult Participants With Moderate-to-severe Asthma Status COMPLETED Phase PHASE2
NCT05018806 Proof of Concept Study of Rilzabrutinib in Adult Patients With Moderate-to-severe Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT05002777 Efficacy, Safety and Pharmacokinetics of Rilzabrutinib in Patients With Warm Autoimmune Hemolytic Anemia (wAIHA) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04562766 Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04520451 Open Label Two-Arm Study to Evaluate Rilzabrutinib in IgG4-Related Disease Participants Status COMPLETED Phase PHASE2
NCT03395210 A Study of Rilzabrutinib in Adult Patients With Immune Thrombocytopenia (ITP) Status COMPLETED Phase PHASE2